187 related articles for article (PubMed ID: 10506849)
1. The state of lipid peroxidation and antioxidants following thrombolytic therapy with rt-PA and streptokinase in acute myocardial infarction.
Ozmen D; Boydak B; Mutaf I; Zoghi M; Kumanlioğlu K; Güner I; Bayindir O
Jpn Heart J; 1999 May; 40(3):267-73. PubMed ID: 10506849
[TBL] [Abstract][Full Text] [Related]
2. Lipid peroxidation and antioxidant status following thrombolytic therapy for acute myocardial infarction.
Young IS; Purvis JA; Lightbody JH; Adgey AA; Trimble ER
Eur Heart J; 1993 Aug; 14(8):1027-33. PubMed ID: 8404932
[TBL] [Abstract][Full Text] [Related]
3. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
4. Plasma antioxidants and lipid peroxidation in acute myocardial infarction and thrombolysis.
Levy Y; Bartha P; Ben-Amotz A; Brook JG; Dankner G; Lin S; Hammerman H
J Am Coll Nutr; 1998 Aug; 17(4):337-41. PubMed ID: 9710842
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
[TBL] [Abstract][Full Text] [Related]
6. Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction.
Mounsey JP; Skinner JS; Hawkins T; MacDermott AF; Furniss SS; Adams PC; Kesteven PJ; Reid DS
Br Heart J; 1995 Oct; 74(4):348-53. PubMed ID: 7488444
[TBL] [Abstract][Full Text] [Related]
7. A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study).
Taylor GJ; Moses HW; Koester D; Colliver JA; Katholi RE; Dove JT; Woodruff RC; Mikell FL; Becker LC; Sheehan FH
Am J Cardiol; 1993 Nov; 72(14):1010-4. PubMed ID: 8213579
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biochemical predictors affect the choice and the short-term outcomes of different thrombolytic agents in acute myocardial infarction.
El-Menyar AA; Altamimi OM; Gomaa MM; Dabdoob W; Abbas AA; Abdel Rahman MO; Bener A; Albinali HA
Coron Artery Dis; 2006 Aug; 17(5):431-7. PubMed ID: 16845251
[TBL] [Abstract][Full Text] [Related]
9. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
10. [The influence of thrombolytic therapy on selected parameters of left ventricular function in acute myocardial infarction].
Wrzesiński K; Kopaczewski J; Wlazłowski R; Gawor Z; Goch JH
Pol Arch Med Wewn; 1999 Jun; 101(6):495-502. PubMed ID: 10754735
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
12. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
Chesebro JH; Knatterud G; Roberts R; Borer J; Cohen LS; Dalen J; Dodge HT; Francis CK; Hillis D; Ludbrook P
Circulation; 1987 Jul; 76(1):142-54. PubMed ID: 3109764
[TBL] [Abstract][Full Text] [Related]
13. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
[TBL] [Abstract][Full Text] [Related]
14. Designing thrombolytic agents: focus on safety and efficacy.
Collen D
Am J Cardiol; 1992 Jan; 69(2):71A-81A. PubMed ID: 1729881
[TBL] [Abstract][Full Text] [Related]
15. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
[TBL] [Abstract][Full Text] [Related]
16. Plasma iron status and lipid peroxidation following thrombolytic therapy for acute myocardial infarction.
Cottin Y; Doise JM; Maupoil V; Tannière-Zeller M; Dalloz F; Maynadié M; Walker MK; Louis P; Carli PM; Wolf JE; Rochette L
Fundam Clin Pharmacol; 1998; 12(2):236-41. PubMed ID: 9565780
[TBL] [Abstract][Full Text] [Related]
17. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
Wackers FJ; Terrin ML; Kayden DS; Knatterud G; Forman S; Braunwald E; Zaret BL
J Am Coll Cardiol; 1989 Apr; 13(5):998-1005. PubMed ID: 2494246
[TBL] [Abstract][Full Text] [Related]
18. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
Goodman SG; Langer A; Ross AM; Wildermann NM; Barbagelata A; Sgarbossa EB; Wagner GS; Granger CB; Califf RM; Topol EJ; Simoons ML; Armstrong PW
Circulation; 1998 Feb; 97(5):444-50. PubMed ID: 9490238
[TBL] [Abstract][Full Text] [Related]
19. Time course of erythrocyte antioxidant activity in patients treated by thrombolysis for acute myocardial infarction.
Simić D; Mimić-Oka J; Pljesa M; Milanović D; Radojević S; Ivanović B; Kalimanovska-Ostrić D; Matić D; Simić T
Jpn Heart J; 2003 Nov; 44(6):823-32. PubMed ID: 14711178
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress after acute myocardial infarction: effect of thrombolytic treatment.
Kharb S; Singh V; Ghalaut PS; Singh GP
J Assoc Physicians India; 2000 Jun; 48(6):578-80. PubMed ID: 11273533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
